Assisted Reproductive Technology Market
Assisted Reproductive Technology Market
Polaris Market Research projects the global assisted reproductive technology market to reach a valuation of nearly USD 50.24 billion by the end of 2034 from USD 28.66 billion in 2024, registering a CAGR of 5.8% during the forecast period from 2025 to 2034.
Market Explanation
Assisted Reproductive Technology (ART) refers to medical procedures aimed at achieving pregnancy through various fertility treatments. These complex interventions involve handling gametes, eggs or sperm, to increase the chances of fertilization. ART is often considered an option for individuals or couples for whom standard infertility treatments have been unsuccessful, or for those who have previously tried to conceive without success. Individuals exploring ART typically consult with healthcare professionals and may require guidance from a fertility specialist to understand their options and choose the most appropriate treatment.
One of the most common forms of ART is in vitro fertilization (IVF), in which a doctor retrieves eggs and fertilizes them with sperm in a specialized laboratory. The resulting embryos can then be transferred into the uterus through a process known as embryo transfer (IVF-ET). Patients may also use tools like the IVF success estimator to assess their likelihood of achieving pregnancy through IVF. Some ART procedures are similar to IVF but involve laparoscopic surgery to place the gametes directly into the fallopian tubes, offering alternative pathways to conception based on specific medical needs.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/assisted-reproductive-technology-market/request-for-sample
Market Drivers
Growing Cases of Infertility: The growing cases of infertility cause market growth. Several factors contribute to this rising concern, including delayed childbearing as individuals prioritize education and careers, lifestyle changes such as inadequate diet and dearth of exercise and increasing exposure to ecological contaminants. Medical conditions such as (PCOS), endometriosis, and sexually transmitted infections also play a part in surging infertility, fuelling the assisted reproductive technology market expansion.
Technological Progressions: Ongoing progressions in medical technologies within the domain of assisted reproductive technology are an important market driver. Innovations such as Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Testing (PGT), and progressive embryo cryopreservation methodologies, together with smart fertility trackers, have notably enhanced the success rates of ART processes.
Company Insights
The industry is excessively competitive, characterized by many contenders striving for market dominance. Major companies are noted below:
• Boston IVF (IntegraMed Fertility)
• CooperSurgical, Inc. (The Cooper Companies, Inc.)
• Esco Micro Pte. Ltd.
• FUJIFILM Irvine Scientific, Inc. (FUJIFILM Holdings Corporation)
• Genea Biomedx Pty Ltd
• IVFtech a.s.
• Kitazato Corporation
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Vitrolife AB
Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/assisted-reproductive-technology-market/inquire-before-buying
Assisted Reproductive Technology Market Report Highlights:
🔹 By type, In-vitro fertilization (IVF) currently holds the largest share of the Assisted Reproductive Technology market globally. This is primarily due to its higher success rates in addressing a broader spectrum of infertility issues compared to other ART procedures, making it the preferred choice for many facing complex fertility challenges worldwide.
🔹 By end use, fertility clinics & other facilities presently command the largest share of the Assisted Reproductive Technology market. Their specialized focus, advanced infrastructure, and concentration of expert medical professionals make them the primary destination for individuals and couples seeking comprehensive ART services globally.
🔹 By region, North America and Europe have historically been key regions, characterized by well-established healthcare infrastructure, high awareness of ART procedures, and supportive regulatory frameworks in many countries. The Asia Pacific region is emerging as a high-growth area, fueled by increasing medical tourism, rising disposable incomes, and a growing acceptance of ART as a solution for infertility.
Market Segmentation
The assisted reproductive technology market is broadly segmented based on type, end use, and region.
Based on type, the in-vitro fertilization segment accounts for the largest market share, driven by elevated success rates in address a broader gamut of infertility problems as contrasted to other ART processes.
Based on end use, the fertility clinics & other facilities segment accounts for the largest revenue share owing to the specific nature of these facilities, which are dedicated solely to offering a thorough range of ART services.
By Type Outlook (Revenue-USD Billion, 2020-2034)
• In-Vitro Fertilization (IVF)
• Artificial Insemination
By End Use Outlook (Revenue-USD Billion, 2020-2034)
• Fertility Clinics & other facilities
• HospitalsOthers
Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/assisted-reproductive-technology-market
Regional Insights
By Regional Outlook (Revenue-USD Billion, 2020-2034)
📊 North America
» US
» Canada
📊 Europe
» Germany
» France
» UK
» Italy
» Spain
» Netherlands
» Russia
» Rest of Europe
📊 Asia-Pacific
» China
» Japan
» India
» Malaysia
» South Korea
» Indonesia
» Australia
» Vietnam
» Rest of Asia-Pacific
📊 Middle East & Africa
» Saudi Arabia
» UAE
» Israel
» South Africa
» Rest of Middle East & Africa
📊 Latin America
» Mexico
» Brazil
» Argentina
» Rest of Latin America
More Trending Reports by Polaris Market Research:
U.S. Sterilization Services Market:
https://www.polarismarketresearch.com/industry-analysis/us-sterilization-services-market
Refurbished MRI Systems Market:
https://www.polarismarketresearch.com/industry-analysis/refurbished-mri-systems-market
U.S. Veterinary Oncology Diagnostics Market:
https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market
Gene Silencing Market:
https://www.polarismarketresearch.com/industry-analysis/gene-silencing-market
Market Leaders Influencing the Future of Telemedicine Equipment Market in 2025:
https://www.polarismarketresearch.com/blog/market-leaders-influencing-the-future-of-telemedicine-equipment-market-in-2025
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
This release was published on openPR.